The aging research field stands at a critical juncture where scientific breakthroughs must align with societal needs and ethical considerations. A multidisciplinary gathering in Lisbon has produced what may become an influential roadmap for prioritizing future investigations into human longevity and healthspan extension.
The inaugural GIMM Festival brought together an unusually diverse coalition of stakeholders—from molecular biologists and clinicians to artists and community advocates—to identify the most pressing questions that should guide aging research over the next decade. This collaborative approach reflects growing recognition that longevity science cannot advance in isolation from broader social implications. The structured discussions yielded consensus priorities that span basic mechanisms of cellular aging, translational interventions, and societal preparedness for extended lifespans.
This type of field-wide strategic planning represents a maturing of longevity research from scattered individual investigations toward coordinated scientific priorities. The inclusion of non-scientific voices—artists and civil society representatives—signals awareness that life extension technologies will reshape social structures, economic systems, and cultural norms in ways researchers alone cannot anticipate. Previous aging conferences typically focused on presenting completed research rather than collectively defining future directions.
The Gulbenkian Institute's initiative could influence funding agencies and research institutions worldwide as they allocate resources for aging studies. However, the ultimate value will depend on whether the identified questions translate into actual research programs and whether the broader scientific community adopts these priorities. The challenge lies in maintaining this multidisciplinary perspective as investigations move from conceptual frameworks into specific laboratory work and clinical trials.